An Adult Thymic Stromal-Cell Suspension Model for in Vitro Positive Selection by Chidgey, Ann P. et al.
Developmental Immunology, 1998, Vol. 6, pp. 157-170
Reprints available directly from the publisher
Photocopying permitted by license only
(C) 1998 OPA (Overseas Publishers Association)
N.V. Published by license under the
Harwood Academic Publishers imprint,
part of the Gordon and Breach Publishing Group
Printed in Malaysia
An Adult Thymic Stromal-Cell Suspension Model for In
Vitro Positive Selection
ANN P. CHIDGEYa* HANSPETER PIRCHERb H. ROBSON MACDONALD RICHARD L. BOYD
aDepartment of Pathology and Immunology, Monash Medical School, Commercial Rd., Prahran 3181, Australia; bDepartment of
Immunology, Institute for Medical Microbiology and Hygiene, University of Freiburg, Germany; CLudwig Institute for Cancer Research,
1066 Epalinges, Switzerland
(Received 20 January 1997; Accepted 19 August 1997)
Presented here is a cell-suspension model for positive selection using thymocytes from cq3-TCR
(H-2Db-restricted) transgenic mice specific to the lymphocytic choriomeningitis virus (LCMV)
on a nonselecting MHC background (H-2’ or TAP-1 -/-), cocultured with freshly isolated adult
thymus stromal cells of the selecting MHC type. The thymic stromal cells alone induced positive
selection of functional CD4-CD8 cells whose kinetics and efficiency were enhanced by
nominal peptide. Fibroblasts expressing the selecting MHC alone did not induce positive
selection; however, together with nonselecting stroma and nominal peptide, there was inefficient
positive. These results suggest multiple signaling in positive selection with selection events able
to occur on multiple-cell types. The ease with which this model can be manipulated should
greatly facilitate the resolution of the mechanisms of positive selection in normal and
pathological states.
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INTRODUCTION
Engagement of the TCR is a pivotal step in thymocyte
development, ultimately resulting in the survival
(positive selection) or loss (negative selection) of
developing T cells. The molecular and cellular
interactions necessary for these selection events,
however, are still poorly understood. MHC trans-
fected fibroblast lines (Pawlowski et al., 1993) and
cloned thymic epithelial-cell lines (Hugo et al., 1992;
Vukmanovic et al., 1992) were able to induce positive
*Corresponding author.
selection after intrathymic injection. However, the
possibility for multicellular involvement--fibroblasts
providing the selecting MHC combined with appro-
priate thymic epithelial cells delivering inducing
signals--has not been addressed.
In conjunction with TCR transgenic mice, fetal
thymic organ culture (FTOC) has been a useful in
vitro model for investigating the effects of peptide in
thymic selection processes (Ashton-Rickardt et al.,
1994; Hogquist et al., 1994; Sebzda et al., 1994).
Reaggregate FTOC have also been developed to
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include defined populations of T-cell precursors and
embryonic stroma (Anderson et al., 1994; Mer-
kenschlager and Fisher, 1994). However, in these
FTOC models, embryonic thymi are the source of T-
cell precursors and stroma, yet the nature of the
embryonic thymus differs markedly from that of the
adult (Boyd et al., 1993). Hence, they may be
inappropriate to study the mechanisms and cellular
involvement in adult thymic positive selection and
abnormalities therein that are manifest postnatally.
Furthermore, the downregulation of RAG-1
expression in immature CD4+CD8 thymocytes
(Brandle et al., 1992; Kouskoff et al., 1995), a
common source of precursor cells for some current
assays for positive selection, indicates that cells at this
stage may have already received selection signals in
vivo, prior to culture. We thus sought to develop an in
vitro model for positive selection that uses adult
stroma and requires minimal pretreatment of T-cell
precursors yet eliminates the possibility that selection
signals had already occurred in vivo.
This cell-suspension model is more easily manipu-
lated and should enable a more detailed dissection of
the thymic stromal elements involved in adult thymic
selection and hence allow investigations into possible
thymic selection detects present in autoimmune
diseases.
RESULTS
An Adult Thymic Stromal-Cell-Suspension
Model for In Vitro Positive Selection
The basic method is outlined in Figure 1. P14
transgenic mice expressing a TCR (V/38.1, Vce2)
specific for the LCMV glycoprotein peptide (amino
acid sequence 33-41; KAVYNFATM), restricted to
H-2Db, were bred onto a nonselecting MHC (H-2d)
background. Rag-1 expression is not downregulated
in TCR transgenic CD4+CD8 thymocytes on a
nonselecting MHC background, suggesting that posi-
tive selection signals had not occurred (Kouskoff et
al., 1995). Day 17-18 gestation was optimal for target
cells since we found this was the earliest age with
significant levels of CD4+CD8 cells and minimal
rearrangement of the endogenous Vce chain that
would have occurred. Selecting (C57B 16; H2b) stro-
mal cells were freshly purified with minimal enzyme
treatment to reduce potential loss of relevant surface
molecules. The stromal cells were comprised essen-
tially of cortical thymic nurse cells (---30%) and other
epithelial cells (--30%), fibroblasts (--5%), macro-
phages and dendritic cells (--20%), endothelial cells
(--5%), and lymphocytes (lymphocyte:stromal cell
ratio of--2:1). In these studies, multiple cell types
were deliberately kept to more closely mimic the
normal thymus. Current work involves separating
individual cell types.
The transgenic thymocyte to adult stromal cell ratio
was 5:1. A three-dimensional structure necessary to
support the development ofT cells was maintained by
culturing the cell suspension as hanging drops. This
also allows for maximum gaseous exchange and for
the contact of T-cell precursors with stromal cells at
the meniscus. Furthermore, as a cell suspension in
28-30/xl, the diffusion of cytokines important for cell
viability and thymic selection is not hampered or too
dilute. Although this system allows some three-
dimensional structure to be retained, the cells were
still essentially a suspension at the end of the 5-day
culture. The nominal LCMV peptide (amino acids
33-41; KAVYNFATM) was usually added once at the
beginning of culture at concentrations ranging from
10-4 to 10-14 M. As peptides degrade in the presence
of fetal calf serum (FCS), in some experiments, the
LCMV peptides were also added on a daily basis at
concentrations ranging from 10-5 to 10-14 M. The
P14 transgenic precursors were distinguished from
the stroma-associated lymphocytes by use of Ly 5
congenic mice (for H-2b stroma) or by MHC class I
haplotype (for H-2k stroma).
De Novo Positive Selection of CD4-CD8 Cells
When Cocultured with Selecting MHC Stroma
The El7 transgenic (H-2d) cells remained at the
CD4+CD8 stage by day 5 when cultured alone or
with nonselecting MHC stroma (H-2k) in the absence
Figure 2A, top panel) or presence of nominal LCMV
peptide (Figure 2A, lower panel) with apoptosis, asMODEL FOR ADULT THYMIC SELECTION 159
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FIGURE Essentially, the co-culture system involves gently digesting adult (3- to 5-week-old) H-2b thymi with enzymes then enriching
for stromal cells by zonal unit-gravity elutriation. These freshly prepared stromal cells were then co-cultured in hanging drops with El7 T-
cell precursors from P14 TCR transgenic mice specific for the lymphocytic choriomeningitis virus (on a nonselecting background), over a
period of 4 to 5 days in the absence or presence of nominal LCMV peptide.160 ANN E CHIDGEY et al.
defined by the CD41CD81 phenotype (Swat et al.,
1991) evident. Similarily, when cultured only with H-
2b lymphocytes, the transgenic cells remained at the
double-positive stage, but there was substantial apop-
tosis in the presence of 10-5 M peptide, consistent
with previous work showing that thymocytes can self-
tolerize (Pircher et al., 1992). When cultured with H-
2b-expressing fibroblasts (MC57), they also remained
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FIGURE 2 CD4-CD8 cells develop when CD4+CD8 P14 transgenic thymocytes are cultured in cell suspension with selecting MHC
stroma but not with nonselecting MHC stroma. (A) To show that CD8 cells were not preselected, day-17 embryonic (El7) P14 transgenic
thymocytes (H-2Db-restricted, on a H-2 background) were cultured alone or in the presence of nonselecting (H-2k) stroma. To illustrate the
importance of selecting stroma in positive selection, El7 transgenic cells were co-cultured with H-2 lymphocytes, H-2b-expressing
fibroblasts (MC57), or selecting stroma (H-2b; Ly 5.1 C57B 16). These co-cultures were set up in the absence (top panel) and presence
(bottom panel) of the nominal LCMV peptide (amino acids 33-41; KAVYNFATM) at a concentration of 10-5 M as described in Materials
and Methods. After 5 days, cells were counted and analyzed by FACS. Transgenic cells were distinguished from stromal-related lymphocytes
by Ly 5.2 or H-2 expression, then analyzed for CD4 and CD8 expression. Typical CD4 vs. CD8 profiles of transgenic cells are shown. (B)
El7 transgenic cells were presorted for CD4+CD8 thymocytes to eliminate the possibility that immature CD8 intermediate cells at El7 were
merely expanding in culture. These CD4+CD8 cells were cocultured with H-2 stroma in the absence of peptide as described and harvested
on day 5. CD4 vs. CD8 profiles of recovered transgenic cells are shown. To illustrate that these cocultures can also support the differentiation
of double-negative cells, CD4-CD8- cells were cocultured with H-2 stroma and harvested on day 5. CD4 vs. CD8 profiles of recovered
transgenic cells are shown.MODEL FOR ADULT THYMIC SELECTION 161
CD4+CD8+, suggesting that MHC alone cannot
induce positive selection (Figure 3). As a positive
control, the LCMV-pulsed MC57 cells were able to
activate mature T cells derived from the thymus or
periphery of LCMV-transgenic H-2b mice (data not
shown).
When the transgenic thymocytes were cocultured
with selecting (H-2b) stroma, however, significant
levels of CD4-CD8 cells developed (--15% of total
cells) by day 5 (Figure 2A). This compares favorably
with the in vivo situation; in the H-2b transgenic
thymus (selecting MHC environment), approximately
18% of cells are single-positive for CD8. Given that
peptides rescue positive selection in FTOC using
lobes deficient in MHC class I/peptide complexes
(Ashton-Rickardt et al., 1993; Hogquist et al., 1993;
Sebzda et al., 1994), we examined the influence of the
nominal LCMV peptide added at the onset of
coculture. Positive selection was enhanced to approxi-
mately 40% in the presence ofLCMV peptide at 10-5
M (Figure 2A). The reduced level of CD4+CD8 cells
in the presence of nonselecting H-2k stroma, relative
to the other control cultures, is unlikely to be due to
increased cell death, but rather to the presence of
macrophages in the stromal preparation that we have
shown avidly phagocytose presumably apoptotic
CD4+CD8 cells within 48 to 72 hr (Izon et al.,
1989).
Absolute transgenic cell numbers recovered from
cocultures with selecting MHC thymic stroma dem-
onstrated at least a tenfold increase relative to
cocultures with nonselecting stroma in the absence of
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’12
"
", --, ...,." )’. -,’1".’,13,’. _’’I-N’-: ,
CD8
FIGURE 3 Positive selection can occur by multicellular signaling. E17 transgenic cells when (A) cultured alone or in the presence of H-2
expressing fibroblasts (C) with or (B) without nominal peptide, do not differentiate into CD4-CD8 cells. However, when El7 transgenic
cells are cocultured with H-2b-expressing fibroblasts and nonselecting (H-2k) stroma in the presence of the nominal LCMV peptide, some
induction of CD4-CD8 cells is evident.162 ANN R CHIDGEY et al.
TABLE Total No. of Recovered Transgenic Thymocytes ( 10-4/106 original El7 Tg cells)
Co-culture Tg alone Tg + H-2 Str Tg + H-2 Ly Tg + MC57 Tg + H-2 Str Tg(4+8+) + H-2 Str Tg(4-8-) + H-2 Str
No peptide 1.2 _+ 0.1 0.4 _+ 0.05 1.5 0.5 0.4 _
0.1 4.5 0.5 6.0 0 7.5 0
10-5 M LCMV 1.7 0.3 0.3 0.1 2.5 1.0 0.5 _+ 0.1 7.1 _+ 1.2
10-1 M LCMV 6.5 +_ 1.0
aNumbers represent mean S.E.M., with n 2 to 8.
TABLE II Total No. of Recovered CD4-CD8 Transgenic Thymocytes ( 10-3/106 original El7 transgenic cells)
Co-culture Tg alone Tg + H-2 Str Tg + H-2 Ly Tg + MC57 Tg + H-2 Str Tg(4+8+) + H-2 Str Tg(4-8-) + H-2 Str
No peptide 0.1 0.01 0.05 0.01 0.15 0.01 0.04 _+ 0.01 11.0 _+ 1.0 6.0 _+ 0 7.5 0
10-5 M LCMV 0.2 _
0.04 0.08 _+ 0.04 0.25 0.01 0.05 0.01 18.0 4.0
10-1 M LCMV 39.0 _+ 1.0
aNumbers represent mean _+ S.E.M., with n 2 to 8.
peptide, and an approximately twentyfold increase in
the presence of the nominal LCMV peptide (Table 1).
Only approximately 1% of transgenic cells (pre-
dominantly CD4+CD8 cells) were recovered after 5
days in culture in the absence of selecting stroma,
compared to 6-7% in the presence of selecting stroma.
Clearly, a large amount of cell loss is evident
regardless of the single specificity of the transgenic
TCR, most likely due to the sensitivity of immature
thymocytes in culture. Despite this, the efficiency of
positive selection in this model is approximately
5-10%, which compares favorably with intrathymic
injections of target thymocytes (Lundberg and Short-
man, 1994). Compared to transgenic cells cocultured
with nonselecting stroma, there was a 200-fold
increase in CD4-CD8 cells recovered when trans-
genic cells were cocultured with selecting stroma. A
similar increase was evident in the presence of 10-5
M nominal LCMV peptide; many transgenic cells
would have been initially deleted due to the high
concentration of peptide. In the presence of 10-7 M
LCMV, there was a 300-fold increase in CD4-CD8
cells, and at 10-l M LCMV, there was 500-fold
increase (Table 2).
Upregulation of the TCR as a consequence of
positive selection is clearly demonstrated in Figure 4.
Prior to culture, the El7 transgenic thymocytes
contained virtually no TCRhi CD4-CD8 cells, as
shown by their Vc2 expression (Figure 4). Identical
profiles were obtained for V/38 expression (data not
shown). The El7 CD4+CD8 cells and CD4-CD8
intermediates in particular showed low TCR
expression, in contrast to transgenic CD4-CD8 cells
induced when cocultured with selecting MHC stroma
in the presence or absence of the nominal LCMV
peptide (Figure 4).
CD4-CD8 Cells Developed De Novo from
Presorted CD4+CD8 Cells
To further establish that the CD4-CD8 cells
developed de novo and were not due to proliferation
of preexisting mature cells, the El7 transgenic cells
(H-2d) were presorted into CD4+CD8 and
CD4-CDS- populations prior to coculture with H-2
b
stroma. In both cases, significant levels (16-23%) of
CD4-CD8 cells developed by day 4 of culture even
in the absence of nominal peptide (Figure 2B). We
also examined the phenotypic and functional status of
the minor subset of El7 CD4-CD8 cells (4-8%)
present in the nonselecting MHC thymus. In accord-
ance with their low TCR status, these cells were
immature intermediates since they were uniformly
TSA-1 hi (Godfrey et al., 1992) and HSAhi (Figure 5)
and rapidly lost in culturemby 48 hr, 94% of the cells
were CD4+CD8 (Figure 6). This clearly demon-
strates that CD4-CD8 cells do not originate from
preexisting single-positive cells and that the co-MODEL FOR ADULT THYMIC SELECTION 163
Tg+H-2b stroma Tg+H-2b stroma
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FIGURE 4 CD4-CD8 positively selected transgenic cells have upregulated the TCR. Histograms show Va2 expression of preculture El7
(H-2d) transgenic CD4-CD8 cells (solid line) and postcoculture CD4-CD8 cells (shaded histogram). Transgenic cells (H-2d; El7) were
cocultured with H-2 stroma (Ly 5.1; C57B16) in the absence or presence of nominal LCMV peptide at a concentration of 10-7 M, for 5
days. Cells were harvested and analyzed by FACS. Transgenic cells were distinguished by Ly 5.2 expression.
culture system can support positive selection from
double-negative cells presumably via CD4+CD8
intermediates since these develop within 24 to 48 hr
when the CD4-CD8- cells are cultured alone (data
not shown). Finally, if the CD4-CD8 cells at the end
of culture are simply preexisting mature cells, they
would be expected to preferentially survive in cul-
tures of transgenic thymocytes alone and even more
so to proliferate in the presence of peptide-pulsed
antigen-presenting cells. In neither case was this
observed (Fig 6: Tg alone; Fig 3: Tg + MC57) even
with irradiated H-2b splenocytes as a source of
antigen-presenting cells and 10-5 or 10-8 M LCMV
peptide, conditions that vigorously stimulate thymo-
cytes and lymph nodes from LCMV transgenic H-2b
mice (data not shown).
As an alternative source of transgenic thymocytes
that have not received prior positive selection signals
in vivo, we made use of P14 TCR transgenic mice on
a TAP-1-deficient (H-2b) background, where develop-
ment of CD4-8 but not CD+CD8 cells is arrested
(Ashton-Rickardt et al., 1993). Neonatal transgenic
thymocytes from these mice were further depleted of
CD4-CD8 cells by sorting for CD4+T cells (leaving
only CD4+8 and CD4+8 cells) prior to coculturing
with freshly purified thymic stroma from H-2b or H-2k
mice. By day 4, TCRhi CD4-CD8 cells were evident,
but only with the H-2b thymic stroma, clearly
demonstrating de novo positive selection in the
CD4+CD8 precursors, driven by endogenous or FCS-
derived peptide. In these cultures, CD4-CD8 cell
numbers increased from 0 to 2-3 104 cells per 106
original transgenic cells by day 4 (data not shown).
Positively Selected CD8 Cells Are Functionally
Mature
The positively selected CD4-CD8 cells were func-
tionally mature both in terms of proliferation and
cytotoxicity. Transgenic El7 thymocytes (H-2d) were
cultured alone or with selecting (H-2b) or non-
selecting (H-2
d or H-2k) thymic stroma in the absence
or presence of 10-7M nominal LCMV peptide for 5
days. The stroma had been irradiated to prevent any
contribution by the stroma-associated lymphocytes.
After the primary coculture, the cells were harvested
and further cultured for 2 days with fresh irradiated
H-2b spleen cells as a source of antigen-presenting
cells that had been pulsed with LCMV peptide.
Transgenic cells when initially cultured alone or with164 ANN E CHIDGEY et al.
nonselecting stroma for 5 days, in the absence and
presence of specific peptide, showed no proliferation
when challenged with fresh antigen-presenting cells
loaded with LCMV peptide (10-6M), nor were they
able to specifically lyse LCMV- (10-SM) loaded EL4
target cells. Transgenic cells cultured with selecting
stroma in the absence and presence of peptide for 5
days, however, proliferated in response to LCMV-
(10-6M) loaded antigen presenting cells (Figure 7).
Phenotypically, these cells remained CD4-CD8hi and
were able to specifically lyse LCMV- (10-SM) loaded
EL4 target cells (Table 3).
CD69 Expression
The early T-cell activation marker, CD69, is tran-
siently expressed during thymocyte selection, both
positive and negative (Swat et al., 1993; Brandle et
al., 1994). In the standard El7 P14 transgenic H-2d
thymocyte/H-2b thymic stroma cocultures without
NON A. SELECTING
E17 THYMUS
SELECTING
LYMPH NODE
SELECTING
THYMOCYTES
CD4+CD8+ CD41OCD8+ CD4-CD8+
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FIGURE 5 CD4-CD8 cells at E17 are immature intermediates. E17 transgenic thymocytes from a nonselecting background (H-2) were
analyzed for expression of HSA and comparisons made with thymocytes and lymph nodes from a transgenic mouse on a selecting
background (H-2b). (A) HSA expression on CD4+CD8+, CD4CD8+, and CD4-CD8 subsets shows that thymocytes from a nonselecting
background maintain high HSA expression in all subsets. (C) Transgenic thymocytes from a selecting background show high HSA
expression on CD4+CD8 cells with downregulation evident on CD4CD8 and CD4-CD8 cells indicating differentiation into mature T
cells. (B) More complete downregulation has occurred on the fully mature T cells in the periphery.MODEL FOR ADULT THYMIC SELECTION 165
LCMV peptide, CD69 increased from <5% at day 0,
to 20-25% by day 2, reaching a maximum of
approximately 50% at day 4. With 10-5 M LCMV
peptide, there was a biphasic expression of CD69
(data not shown); the initial increase (day 1) coin-
cided with the negative selection of transgenic cells
with high concentration of peptide, consistent with
recent findings that CD69 is also expressed on the
surface of apoptosing cells (Kersh and Hedrick, 1995;
Kishimoto et al., 1995). The second increase in CD69
(day 3) would be a consequence of positive selection.
CD5 is another cell-surface molecule that is upregu-
lated during positive selection (Fowlkes et al., 1985;
Lanier et al., 1986). We also found CD5 was
upregulated on the selected single-positive CD8 cells
in the co-cultures (data not shown), providing further
evidence for de novo positive selection.
Positive Selection Can Involve Multiple-Cell
Types
Positive selection was not induced in the presence of
nonselecting MHC stroma. To determine whether
MHC alone can positively select, El7 transgenic
thymocytes were cocultured with H-2Db expressing
MC57 cells for 5 days. No positive selection was
evident in cocultures in the absence or presence of the
LCMV peptide. However, when nonselecting stroma
was included with 10-5 M LCMV peptide and MC57
cells, 11% of total transgenic cells were of the
CD4-CD8 phenotype at day 5 (Figure 3).
DISCUSSION
To date, thymocyte selection has been primarily
studied in the embryonic thymus, but how well this
DAY 1 DAY 2
DAY 3
910
:.’." "2: ’..
DAY 4
CD8
FIGURE 6 Kinetics of transgenic cells cultured alone show that cells do not differentiate beyond the double-positive stage of development.
El7 transgenic thymocytes from a nonselecting background were cultured alone over a 4-day period and analyzed daily for CD4 and CD8
expression.166 ANN E CHIDGEY et al.
mimics that which occurs in the adult thymus is
questionable. Here we present a cell-suspension
model for in vitro positive selection that utilizes adult
stroma, and hence will provide a good comparison
with current fetal thymic models. The ease with which
this system can be manipulated should enable a
detailed dissection of the basis to positive selection,
particularly the early kinetics and gene-activation
events. Furthermore, by using adult stroma, it should
allow investigations into the aetiological significance
of thymic stromal-cell disorders that are manifest in
the postembryonic period.
Essentially, this system involves coculturing trans-
genic thymocyte precursors of known TCR speci-
ficity, but in a nonselecting environment, with
purified adult stroma of the selecting and nonselecting
MHC type. This system has the added advantage of
being able to separate out distinct stromal-cell
subsets, a technique that we are currently investigat-
ing. To avoid the possibility that positive selection
signals had occurred prior to culture but were not yet
apparent, and to minimize the preculture handling of
precursor T cells, we used El7 thymocytes from TCR
transgenic mice specific to LCMV/H-2b, which were
maintained on a nonselecting MHC (H-2) or a TAP-
1-deficient background. This is the first stage where
CD4+CD8 cells are evident; these and a low
percentage of CD3-CD4-CD8 were TCR-/l,
HSAhi, and TSA-1 hi, confirming their immature
status. After culture alone or in the presence of H-2b-
bearing nonthymic epithelial cells, the latter cells
developed to CD4+CD8 cells and there was no
progression of any cells to the mature CD4-CD8
cells, confirming that these are a consequence of de
novo positive selection in the presence of thymic
epithelium. Selecting stromal cells (H-2b) were
Proliferation
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FIGURE 7 Transgenic cells selected by H-2 stroma in the absence or presence of nominal peptide are functionally mature. CD4-CD8
cells positively selected in the absence or presence of nominal LCMV peptide (10
-7 M), proliferate in response to fresh antigen-presenting
cells loaded with a higher concentration of LCMV peptide (10
-6 M). The transgenic cells when cultured alone show no such
proliferation.MODEL FOR ADULT THYMIC SELECTION 167
TABLE III Positively Selected CD4-CD8 Cells Are Cytolytic
Effector:target Tg alone Tg alone Tg + H-2 Tg + H-2 Tg + H-2 Tg + H-2
ratio (EL4 + lcmv) (EL4) (EL4 + lcmv) (EL4) + 10 M (EL4 + lcmv) + 10 M (EL4)
10:1 0.6 0 71 3.7 57.2 5.1
3.3:1 2.1 0 64.5 2.1 40.3 3.1
1:1 1.4 0 62.2 1.1 26.4 4.3
0.4:1 1.7 0.1 32.7 1.4 17 1.9
0.1:1 2.5 0.3 18.2 0 4 2.8
apositively selected CD4-CD8 cells from cocultures containing selecting H-2 stroma, both in the absence and presence of the nominal
LCMV peptide (10-7 M), were able to specifically lyse target cells that were loaded with the same nominal LCMV peptide at a higher
concentration (10
-5 M). Transgenic cells cultured alone under the same conditions were unable to specifically lyse LCMV-loaded target
cells.
b% specific lysis.
freshly purified to reduce the likelihood that important
surface molecules had been downregulated in cul-
ture.
It has been argued that MHC alone is all that is
required to induce positive selection, with the main
body of evidence being from intrathymic injections of
cell lines expressing the selecting MHC into a
nonselecting thymus (Hugo et al., 1992; Vukmanovic
et al., 1992). These experiments, however, did not
exclude the possibility that accessory signals that may
be required for positive selection were received from
the nonselecting thymic epithelial cells. We found
that positive selectio/a was only observed with thymic
stromal cells and not when transgenic precursors were
cocultured with H-2b-expressing thymocytes, irra-
diated spleen cells, or fibroblasts (MC57) in the
presence or absence of peptide. Positive selection was
evident by the downregulation of the CD4 coreceptor,
upregulation of TCR, and upregulation of CD69 and
CD5. Similarly, Anderson and colleagues have found
in reaggregate thymic organ cultures that thymic
epithelium was essential for positive selection
(Anderson et al., 1996). When the precursors were
cocultured with H-2b-expressing fibroblasts and thy-
mic stroma from a nonselecting MHC background in
the presence of peptide, we did observe some positive
selection, albeit inefficient. Our data are consistent
with the possibility that TCR-peptide/MHC inter-
actions, an essential requirement for positive selec-
tion, work in conjunction with other stromal acces-
sory signals to induce efficient complete positive
selection. Certainly, although positive selection can
be multicellular, it is more efficient if the correct
MHC is coexpressed with appropriate differentiation
molecules on dedicated thymic stroma, presumably
epithelium.
The issue of peptide involvement in positive
selection was briefly investigated using the nominal
agonist LCMV peptide at various concentrations.
Whereas positive selection did occur in the absence of
specific nominal peptide, presumably due to the
presence of endogenous peptide, it was enhanced in
the presence of the LCMV peptide, as indicated by the
increase in CD4-CD8 cell numbers recovered after
culture. This was most evident in cocultures contain-
ing 10-l M LCMV. In cocultures containing higher
concentrations of peptide such as 10-5 M, double-
positive cells initially apoptosed, evident in kinetics
studies (data not shown). By day 1, however, the
double-negative cells that had converted to double-
positive cells were then likely to have been selected at
a concentration of peptide somewhat lower than the
original level, due to degradation of the peptide in the
presence of FCS. The CD4-CD8 cells selected either
on the endogenous peptide or in the presence of the
nominal LCMV peptide were functionally mature,
both in their ability to proliferate in response to
LCMV-peptide-loaded antigen-presenting cells and in
their capacity to specifically lyse LCMV-loaded EL4
target cells. This is significant in the light of recent
publications suggesting that only antagonist peptides
can positively select to produce phenotypically and
functionally mature CD8 T cells.168 ANN E CHIDGEY et al.
In summary, this in vitro model demonstrates all
the salient features of positive selection, and high-
lights the importance of peptide in the efficiency of
selection. This system should enable a more precise
dissection of the stromal cells and the role of naturally
occurring self-peptides and other molecules involved
in the thymic selection processes, and allow early
activation events to be monitored. Furthermore, the
ease with which this model can be manipulated
should greatly facilitate resolution of the aetiological
significance of thymic stromal cells, particularly
epithelium, abnormalities that are manifest post-
natally.
MATERIALS AND METHODS
Mice
P14 TCR transgenic mice, H-2Db-restricted, were
bred onto a nonselecting H-2d background and
maintained at the Monash University animal house.
Ly 5 congenic C57B16 mice and CBA mice were
maintained at the Monash University animal house.
The P14 TCR transgenic mice on a TAP-l-deficient
background were a kind gift from S. Tonegawa, the
Massachusetts Institute of Technology.
Peptides
The nominal LCMV agonist peptide (amino acids
33-41; KAVYNFATM), the original cysteine at
anchor position 41 in the wildtype LCMV peptide
having been replaced by methionine to prevent dimer
formation, were a kind gift from Hanspeter Pircher
(University of Freiburg).
T-Cell Precursors
Transgenic embryonic thymi (E17) from P14 a/3TCR
transgenic mice (specific to the lymphocytic chor-
iomeningitis virus; H-2b-restricted) on a H-2d (Pircher
et al., 1989) or Tap-l-deficient background were the
source of precursor T cells. Cell suspensions were
prepared at a concentration of 3.4 106 cells/ml. To
remove any CD8 single-positive cells, thymocytes
were presorted with CD4-magnetic beads (MACS
Magnetic Microbeads, Miltenyi Biotec GmbH, Ber-
gisch Gladbach, Germany) using a VarioMACS
(VarioMACS, Miltenyi Biotec GmbH, Bergisch
Gladbach, Germany). Enriched cells were mostly of
the CD4+CD8 phenotype with a small population of
CD4+CD8 intermediate cells. In some experiments,
pre-sorted CD4-CD8- or CD4-CD8int cell popula-
tions were also used as target cells.
Stromal-Cell Preparation
Thymic stromal cells were prepared from Ly 5.1
congenic C57B16 mice (H-2b) or CBA-CaH (H-2k)
mice by gentle enzymic (0.15% collagenase/0.1%
DNase; Boehringer Mannheim, Germany) digestion
of lymphocyte-depleted thymi. Cells were enriched to
a lymphocyte to stromal-cell ratio of approximately
2:1 by zonal unit-gravity elutriation, essentially as
described by Lahoud et al. (1993). Cells were
subsequently resuspended in Clicks medium (GIBCO
BRL, Gaithersburg, MD) that had been supplemented
with 10% heat-inactivated FCS (GIBCO BRL), 2mM
L-glutamine (Flow, UK), 0.05% benzyl penicillia
(CSL, Australia), 0.05% streptomycin (Sigma, St.
Louis), 5 10-5 M 2-mercaptoethanol (Sigma) at a
concentration of 6.7 105 cells/ml and pulsed with
peptide at the relevant concentrations.
Co-culture
Transgenic El7 thymocytes were mixed with the
stromal cells at a ratio of 5:1 and co-cultured as
hanging drops in inverted Terasaki plates at 37C, 5%
CO2 generally over a 5-day period. Ly5.2 expression
or MHC class I (S17.71 anti H-2k) distinguished P14
transgenic thymocytes from stromal-associated
lymphocytes. Postculture analysis involved staining
cells with Ly 5.2-FITC (PharMingen, San Diego),
CDS-Biotin/Tricolour (PharMingen), and CD4-PE
(PharMingen), or CD4 APC and Va2 PE (PharMin-
gen). Dead cells were gated out by a lymphocyte
viability gate or by using propidium iodide where
possible. Cells were analyzed by flow cytometry
using a FACScan (Becton-Dickinson, MountainMODEL FOR ADULT THYMIC SELECTION 169
View, CA). Cell population gates were determined
using the nontransgenic stromal-associated lympho-
cyte component of the coculture.
supported by grants from the National Health and
Medical Research Council of Australia.
Functional Assays
Cocultures of P14 H-2d transgenic thymocytes and
freshly purified H-2b stroma were prepared and
analyzed as described before with the addition that
purified stroma was irradiated at 3000 fads prior to
co-culture to prevent proliferation of stroma-asso-
ciated lymphocytes. Cells were harvested at day 5 and
placed into round-bottom wells of a 96-well plate (5
l04 cells/well) with IL-2 (25 units) and 5 105
irradiated (3000 rads) H-2b splenocytes that had been
pulsed with 10-6M LCMV peptide, for 48 hr. For the
proliferation assay, (3H) thymidine was added for 16
hours and incorporated radioactivity measured on a/3
counter. For the cytotoxicity assay, target cells (EL4
cell line) were incubated with 51 Cr, with or without
10-5 M LCMV peptide, for 45 min. Effector cells
were then incubated with target cells for 4 hr in
tripling dilutions, the supernatant removed, and
chromium release measured on a 3/counter. Percent-
age-specific lysis of target cells was calculated by:
cpm test cpm minimum release
100
cpm maximum release cpm minimum release
Statistical Analysis
Viable cells were counted under a fluorescence
microscope using ethidium bromide/acridine orange
and standardized as the number of recovered cells per
106 original El7 put into culture at day 0.
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